Skip Navigation


QJM Advance Access originally published online on August 19, 2006
QJM 2006 99(9):635-637; doi:10.1093/qjmed/hcl086
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/9/635    most recent
hcl086v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Soran, H.
Right arrow Articles by Younis, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soran, H.
Right arrow Articles by Younis, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Commentary

The benefits of insulin therapy following acute myocardial infarction revisited

H. Soran1,, B. Barzangy2 and N. Younis1

From the 1Department of Diabetes & Endocrinology, South Manchester University Hospital, Manchester, and 2New Cross Hospital, Wolverhampton, UK

Address correspondence to Dr H. Soran, Specialist Registrar in Endocrinology and Diabetes, Department of Diabetes & Endocrinology, South Manchester University Hospital, Manchester M20 2LR. email: hsoran@aol.com

The first 10% of the full text of this article appears below.


   Introduction
 
The increased mortality and morbidity from cardiovascular disease associated with diabetes mellitus (DM) is well known.1 Patients with DM but no previous myocardial infarction (MI) have a risk of MI similar to that of non-diabetic patients with a previous history of MI,1 and mortality from acute MI in patients with DM is double that in non-diabetic individuals.2,3 Five-year mortality in patients with DM hospitalized with MI is 75%:3 higher than that for many malignant diseases. In spite of more aggressive and interventional therapies for MI, mortality remains significantly higher in patients with DM, compared with those without.4 There . . . [Full Text of this Article]


   The DIGAMI 2 study
 

   Conclusions
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?